Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 135
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #161: Numinus Shifts Focus to US; Algernon Makes DMT for Stroke Lead Asset; atai Pivots to IV Ibogaine
Rethinking Drug Education: From D.A.R.E. Scare Tactics to an Evidence-Based Approach
Tracking Legal Psychedelics in the U.S. and Worldwide
Updates from MAPS: Current Initiatives, Psychedelic Science 2024, and Music as a Bridge
Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran Singh
COMPASS Pathways plc to announce fourth quarter and full year 2021...
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...
Awakn Files Patent For A New Class Of Entactogen-Like Molecules
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study
PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation
Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism
Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)...
Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study...
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
1
...
134
135
136
...
255
Page 135 of 255